Ocular Ischemic Syndrome (OIS) is a serious eye condition that can cause vision loss. It is caused by a decrease in blood flow to the eye, which can lead to a variety of problems, including damage to the retina, optic nerve, and other parts of the eye. OIS is often referred to as the “silent thief” because it can cause vision loss without any warning signs or symptoms. In this article, we will discuss what OIS is, the causes and risk factors, diagnosis, and treatment options.
Ocular Ischemic Syndrome is a condition that occurs when there is a decrease in the blood supply to the eye. This decrease in blood flow can be caused by a variety of factors, including blockages in the arteries that supply blood to the eye, narrowing of the blood vessels, or damage to the blood vessels. OIS can cause damage to the retina, optic nerve, and other parts of the eye, which can lead to vision loss.
There are several potential causes of OIS, including blockages in the arteries that supply blood to the eye, narrowing of the blood vessels, or damage to the blood vessels. Other risk factors for OIS include diabetes, high blood pressure, high cholesterol, smoking, and advanced age.
OIS can be difficult to diagnose because it often does not cause any symptoms. However, if you are experiencing any vision problems, it is important to see an eye doctor. Your doctor will perform a comprehensive eye exam to look for signs of OIS. This may include tests to measure the pressure inside the eye, an optical coherence tomography (OCT) to look for signs of damage to the retina, and a fluorescein angiography to look for blockages in the blood vessels.
The treatment for OIS depends on the underlying cause. If the cause is a blockage in the blood vessels, your doctor may recommend a procedure to open the blocked vessels. Other treatments may include medications to reduce inflammation, medications to lower blood pressure or cholesterol, or laser treatment to improve blood flow.
Ocular Ischemic Syndrome is a serious eye condition that can cause vision loss. It is caused by a decrease in blood flow to the eye, which can lead to a variety of problems, including damage to the retina, optic nerve, and other parts of the eye. OIS is often referred to as the “silent thief” because it can cause vision loss without any warning signs or symptoms. If you are experiencing any vision problems, it is important to see an eye doctor for a comprehensive eye exam. Treatment for OIS depends on the underlying cause, and may include medications, procedures, or laser treatment.
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation